: Foghorn's stock drops 23% after FDA puts partial hold on clinical trial #FinanceUSA #StockMarketNEWS Shares of Foghorn Therapeutics Inc. were down 23.7% in premarket trading on Friday, the day after
@stockMarketNEWS Sat 21 May, 2022
Foghorn's stock drops 23% after FDA puts partial hold on clinical trial #FinanceUSA #StockMarketNEWS
Shares of Foghorn Therapeutics Inc. were down 23.7% in premarket trading on Friday, the day after the company said U.S. regulators had placed a partial clinical hold on a Phase 1 clinical trial assessing an experimental therapy for relapsed and/or refractory acute myelogenous leukemia. The Food and Drug Administration has asked for a review of the safety database, as well as information about risk mitigation and clinical activity across doses. Foghorn's stock has declined 49.3% this year, while the broader S&P 500 is down 18.1%.
Munafa USA Munafa India Munafa NSE
More posts by @stockMarketNEWS
: Market Extra: ‘Growth scare’ permeates U.S. stocks as estimated trillion to trillion of household wealth evaporates in five months #FinanceUSA #StockMarketNEWS Four Paws/Agence France-Presse
@stockMarketNEWS Sat 21 May, 2022
: S&P 500 slips below bear-market threshold #FinanceUSA #StockMarketNEWS The S&P 500 on Friday traded below 3,837.25, the level that marks a 20% pullback from the large-cap U.S. benchmark's Jan. 3 record
@stockMarketNEWS Sat 21 May, 2022
0 Comments
Sorted by latest first Latest Oldest Best
NSE Gainers NSE Losers BSE Gainers BSE Losers
Munafa NEWSTerms of Use Create Support ticket Your support tickets Powered by ePowerPress Stock Market News! Top Seo SMO © munafa.us2022 All Rights reserved.